BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27181494)

  • 1. Crouzonodermoskeletal Syndrome with Hypoplasia of Corpus Callosum and Inferior Vermis.
    Gürbüz F; Ceylaner S; Topaloğlu AK; Yüksel B
    J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):373-4. PubMed ID: 27181494
    [No Abstract]   [Full Text] [Related]  

  • 2. Crouzon syndrome with acanthosis nigricans: a case-based update.
    Di Rocco F; Collet C; Legeai-Mallet L; Arnaud E; Le Merrer M; Hadj-Rabia S; Renier D
    Childs Nerv Syst; 2011 Mar; 27(3):349-54. PubMed ID: 21136065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous features of Crouzon syndrome with acanthosis nigricans.
    Mir A; Wu T; Orlow SJ
    JAMA Dermatol; 2013 Jun; 149(6):737-41. PubMed ID: 23571469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crouzonodermoskeletal syndrome.
    Jeftha A; Stephen L; Morkel JA; Beighton P
    J Clin Pediatr Dent; 2004; 28(2):173-6. PubMed ID: 14969379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple consequences of a single amino acid pathogenic RTK mutation: the A391E mutation in FGFR3.
    Chen F; Sarabipour S; Hristova K
    PLoS One; 2013; 8(2):e56521. PubMed ID: 23437153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans.
    Meyers GA; Orlow SJ; Munro IR; Przylepa KA; Jabs EW
    Nat Genet; 1995 Dec; 11(4):462-4. PubMed ID: 7493034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acanthosis nigricans in children and Crouzon syndrome].
    Lagaude M; Barreau M; Jokic M; Gerard M; DiRocco F; Hadj-Rabia S; Dompmartin A; Verneuil L
    Ann Dermatol Venereol; 2014 Nov; 141(11):685-8. PubMed ID: 25442473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crouzon syndrome with acanthosis nigricans and prominent diffuse hyperpigmentation associated with gain-of-function A391E mutation in FGFR3 gene.
    Kariya H; Nakano H; Ishii N; Kaimi Y; Imai K; Nakanishi Y; Kunihiro N; Fukai K
    J Dermatol; 2020 Dec; 47(12):e451-e452. PubMed ID: 32860240
    [No Abstract]   [Full Text] [Related]  

  • 9. Crouzon syndrome with acanthosis nigricans: case report and mutational analysis.
    Nagase T; Nagase M; Hirose S; Ohmori K
    Cleft Palate Craniofac J; 2000 Jan; 37(1):78-82. PubMed ID: 10670894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A newborn with acanthosis nigricans: can it be Crouzon syndrome with acanthosis nigricans?
    Sharda S; Panigrahi I; Gupta K; Singhi S; Kumar R
    Pediatr Dermatol; 2010; 27(1):43-7. PubMed ID: 20199409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Let's call it "Crouzonodermoskeletal syndrome" so we won't be prisoners of our own conventional terminology.
    Cohen MM
    Am J Med Genet; 1999 May; 84(1):74. PubMed ID: 10213050
    [No Abstract]   [Full Text] [Related]  

  • 12. [A hypothesis on the pathogeny of rounded and linear epidermal nevi (nevoid acanthosis nigricans)].
    Vabres P
    Ann Dermatol Venereol; 2012 Mar; 139(3):177-9. PubMed ID: 22401680
    [No Abstract]   [Full Text] [Related]  

  • 13. Familial acanthosis nigricans with p.K650T FGFR3 mutation.
    Fukuchi K; Tatsuno K; Matsushita K; Kubo A; Ito T; Tokura Y
    J Dermatol; 2018 Feb; 45(2):207-210. PubMed ID: 29068064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crouzon with Acanthosis Nigricans and Odontogenic Tumors: A Rare Form of Syndromic Craniosynostosis.
    Xu W; McDonald-McGinn DM; Melchiorre AJ; Zackai EH; Bartlett SP; Taylor JA
    Cleft Palate Craniofac J; 2018 Feb; 55(2):296-300. PubMed ID: 29351036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An association of acanthosis nigricans and Crouzon syndrome.
    Koizumi H; Tomoyori T; Sato KC; Ohkawara A
    J Dermatol; 1992 Feb; 19(2):122-6. PubMed ID: 1377724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtle radiographic findings of achondroplasia in patients with Crouzon syndrome with acanthosis nigricans due to an Ala391Glu substitution in FGFR3.
    Schweitzer DN; Graham JM; Lachman RS; Jabs EW; Okajima K; Przylepa KA; Shanske A; Chen K; Neidich JA; Wilcox WR
    Am J Med Genet; 2001 Jan; 98(1):75-91. PubMed ID: 11426459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial acanthosis nigricans due to K650T FGFR3 mutation.
    Berk DR; Spector EB; Bayliss SJ
    Arch Dermatol; 2007 Sep; 143(9):1153-6. PubMed ID: 17875876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial acanthosis nigricans with the FGFR3 mutation: Differences of pigmentation between male and female patients.
    Yasuda M; Morimoto N; Shimizu A; Toyoshima T; Yokoyama Y; Ishikawa O
    J Dermatol; 2018 Nov; 45(11):1357-1361. PubMed ID: 30168875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanding the phenotype for the recurrent p.Ala391Glu variant in FGFR3: Beyond crouzon syndrome and acanthosis nigricans.
    Rymer K; Shiang R; Hsiung A; Pandya A; Bigdeli T; Webb BT; Rhodes J
    Mol Genet Genomic Med; 2019 Jun; 7(6):e656. PubMed ID: 31016899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical signs, interventions, and treatment course of three different treatment protocols in patients with Crouzon syndrome with acanthosis nigricans.
    de Planque CA; Wall SA; Dalton L; Paternoster G; Arnaud É; van Veelen MC; Versnel SL; Johnson D; Jayamohan J; Mathijssen IMJ
    J Neurosurg Pediatr; 2021 Aug; 28(4):425-431. PubMed ID: 34388723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.